Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
在抗水通道蛋白4抗体阳性视神经脊髓炎谱系障碍患者中,使用ravulizumab可立即且持续地抑制末端补体。
期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2024.1332890
Ortiz, Stephan; Pittock, Sean J; Berthele, Achim; Levy, Michael; Nakashima, Ichiro; Oreja-Guevara, Celia; Allen, Kerstin; Mashhoon, Yasmin; Parks, Becky; Kim, Ho Jin